Intravenous methylprednisolone for multiple sclerosis in relapse.
Open Access
- 1 February 1985
- journal article
- clinical trial
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 48 (2) , 157-159
- https://doi.org/10.1136/jnnp.48.2.157
Abstract
A randomised comparison is made between methylprednisolone, 1 g intravenously daily for 7 days, and a standard ACTH regime for the treatment of multiple sclerosis in acute relapse. It is found that methylprednisolone produces a more rapid clinical improvement than ACTH but confers no longer term benefit when the two treatments are compared at 3 months. It is proposed that intravenous methylprednisolone does have a role to play in the management of a patient with an acute relapse of multiple sclerosis.Keywords
This publication has 6 references indexed in Scilit:
- Treatment of acute exacerbations of multiple sclerosis with intravenous methyl-prednisolone.Journal of Neurology, Neurosurgery & Psychiatry, 1982
- Possible beneficial effect of high‐dose intravenous steroid therapy in acute demyelinating disease and transverse myelitisNeurology, 1980
- Prolonged effects of large‐dose methylprednisolone infusion in multiple sclerosisNeurology, 1980
- Cooperative study in the evaluation of therapy in multiple sclerosisNeurology, 1970
- LONG-TERM TREATMENT OF MULTIPLE SCLEROSIS WITH CORTICOTROPHINThe Lancet, 1967
- Further notes on disability evaluation in multiple sclerosis, with scale modificationsNeurology, 1965